Skip to content
← Back to this collection

PUBLICATIONS · 34882493

Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2022 Mar 20
First author
Schultz LM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Schultz LM
      type
      Author
    2. name
      Baggott C
      type
      Author
    3. name
      Prabhu S
      type
      Author
    4. name
      Pacenta HL
      type
      Author
    5. name
      Phillips CL
      type
      Author
    6. name
      Rossoff J
      type
      Author
    7. name
      Stefanski HE
      type
      Author
    8. name
      Talano JA
      type
      Author
    9. name
      Moskop A
      type
      Author
    10. name
      Margossian SP
      type
      Author
    11. name
      Verneris MR
      type
      Author
    12. name
      Myers GD
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Schultz LM
      type
      Author
    2. name
      Baggott C
      type
      Author
    3. name
      Prabhu S
      type
      Author
    4. name
      Pacenta HL
      type
      Author
    5. name
      Phillips CL
      type
      Author
    6. name
      Rossoff J
      type
      Author
    7. name
      Stefanski HE
      type
      Author
    8. name
      Talano JA
      type
      Author
    9. name
      Moskop A
      type
      Author
    10. name
      Margossian SP
      type
      Author
    11. name
      Verneris MR
      type
      Author
    12. name
      Myers GD
      type
      Author
    bibliography ids
    1. nci-bib-31be106c55c6e39cf3ae3035
    book metadata
    content sha256
    dce4a6ed1392bcdfab94467c180921d02daaa1a73eeee1971e21644b9557726f
    document type
    citation
    dois
    1. 10.1200/JCO.20.03585
    electronic publication date
    display
    2021 Dec 9
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34882493
    immutable id
    pubmed:34882493@dce4a6ed1392bcdfab94467c180921d02daaa1a73eeee1971e21644b9557726f
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    9
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    945-955
    volume
    40
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34882493
      provenance
      batch id
      3f4d1914d2afe41e9e70
      provider
      NCBI PubMed ESummary
      record sha256
      d9a89eeb892ddac9c14cae741653170cfbb3f557d8843b2bce72b4aa98d6f3ec
      response sha256
      0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
      retrieved at
      2026-09-09T23:48:06.522634+00:00
      publication date
      display
      2022 Mar 20
      precision
      day
      year
      2022
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34882493/
      title
      Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.

      Preserved source evidence · Not medical advice